Absence of concentration congruity in six compounded polidocanol samples obtained for leg sclerotherapy

Dermatologic Surgery

Volumn 37, Issue 6, 2011, Pages 812-815

  Weiss, Robert A ^a,c,d   Voigts, Robert ^b   Howell, David J ^a  

^a Merz Aesthetics ^*

^b New Product Development   (United States)

^c Skin and Vein Institute   (United States)

^d MD Laser Skin and Vein Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLIDOCANOL;

ARTICLE; DRUG FORMULATION; DRUG IMPURITY; MASS FRAGMENTOGRAPHY; PRIORITY JOURNAL; SCLEROTHERAPY;

EID: 79959837390     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2011.01906..x     Document Type: Article

References (10)

1. Goldman MP. Sodium tetradecyl sulfate for sclerotherapy treatment of veins: is compounding pharmacy solution safe? Dermatol Surg 2004;30:1454-6.
2. Almeda JI, Raines JK. FDA- approved sodium tetradecyl sulfate (STS) versus compounded STS for venous sclerotherapy. Dermatol Surg 2007;33:1037-44. (Pubitemid 47339686)
3. Guex JJ. Indications for the sclerosing agent polidocanol. J Dermatol Surg Oncol 1993;19:959-61.
4. Hamel-Desnos C, Desnos P, et al. Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results. Dermatol Surg 2003;29:1170-5. (Pubitemid 38009913)
5. Rao J, Wildemore JK, Goldman MP. Double-blind prospective comparative trial between foamed and liquid polidocanol and sodium tetradecyl sulphate in the treatment of varicose and telangiecratic leg veins. Dermatol Surg 2005;31:631-5. (Pubitemid 43093412)
6. Saito N, Sasaki S, Sekido M, et al. Efficacy of polidocanol sclerotherapy for capillary malformation with masked venous malformation. Dermatol Surg 2009;35:161-4.
7. Goldman M. Treatment of varicose and telangiectatic leg veins: double-blind, prospective comparative trial between Aethoxyskerol and Sotradecol. Dermatol Surg 2002;28: 52-5. (Pubitemid 34101582)
8. McCoy S, Evans A, Spurrier N. Sclerotherapy for leg telangiectasia - a blinded comparative trial of polidocanol and hypertonic saline. Dermatol Surg 1999;25:381-6. (Pubitemid 29242384)
9. Rabe E, Schliepake D, Otto J, et al. Sclerotherapy of teleangiectases and reticular veins: a double-blind, randomized, comparative clinical trial of polidocanol, sodium tetradecyl sulfate and isotonic saline (EASI study). Phlebology 2010;25: 124-31.
10. Asclera Prescribing Information. San Mateo, CA: Merz Aesthetics; 2010.